Suchergebnisse - "Leong, Stephen"

PubPharm (10)

1

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

enthalten in: Investigational new drugs | 2016

von Kessler, E. | Eckhardt, S. | Pitts, T. | +11

2

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

enthalten in: Investigational new drugs | 2015

von Kessler, E. | Eckhardt, S. | Pitts, T. | +11

3

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

enthalten in: Investigational new drugs | 2015

von Kessler, E. | Eckhardt, S. | Pitts, T. | +11

4

Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

enthalten in: Investigational new drugs | 2015

von Kessler, E. | Eckhardt, S. | Pitts, T. | +11

5

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

enthalten in: Investigational new drugs | 2014

von von Mehren, M. | Britten, C. | Pieslor, P. | +8

6

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

enthalten in: Investigational new drugs | 2014

von von Mehren, M. | Britten, C. | Pieslor, P. | +8

7

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

enthalten in: Investigational new drugs | 2014

von von Mehren, M. | Britten, C. | Pieslor, P. | +8

8

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer

enthalten in: Investigational new drugs | 2010

von Zhou, Q. | Gustafson, D. | Nallapareddy, S. | +9

9

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer

enthalten in: Investigational new drugs | 2010

von Zhou, Q. | Gustafson, D. | Nallapareddy, S. | +9

10

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer

enthalten in: Investigational new drugs | 2010

von Zhou, Q. | Gustafson, D. | Nallapareddy, S. | +9

1
[1]